Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2025 Earnings Call Transcript
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2025 Earnings Call Transcript May 8, 2025Crinetics Pharmaceuticals, Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:CRNX’
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, everyone. Welcome to the Crinetics Pharmaceuticals Fourth Quarter and Full-Year 2024 Financial Results Conference Call.
10 Worst Performing Mid Cap Stocks to Buy According to Analysts
Market analysts are increasingly highlighting mid-cap stocks as a potentially attractive investment opportunity, particularly in the current economic climate.
15 Stocks That Took a Nosedive in January
Historically, the S&P 500's performance in January sets the pace for the rest of the year.
Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Crinetics Pharmaceuticals Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Best Mid-Cap Healthcare Stocks To Buy Now
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q2 2024 Earnings Call Transcript
Operator: Good day everyone, and welcome to the Crinetics Pharmaceuticals Second Quarter 2024 Earnings Conference Call. [Operator Instructions].
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Crinetics Pharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.
2024 SOHN Conference Stock Pitches
We were one of the media sponsors of the 2024 Sohn Investment Conference in New York City on April 3rd and we will be sharing our takeaways with our premium subscribers over the...
Insiders Are Dumping These 5 Healthcare Stocks
This article presents an overview of Insiders Are Dumping These 10 Healthcare Stocks. For a detailed overview of such stocks, read our article, Insiders Are Dumping These 10...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2023 Earnings Call Transcript
Operator: Welcome to the Crinetics Pharmaceuticals Fourth Quarter and Full-Year 2023 Financial Results Conference Call. At this time all participants are in listen-only mode.
12 Stocks Billionaire Steve Cohen Just Bought and Sold
In this article, we're going to take a look at 12 stocks billionaire Steve Cohen just bought and sold.
Top 10 Growth Stocks in Biotech
The biotech industry encompasses a wide range of fields, including genetic engineering, biomanufacturing, bioinformatics, and synthetic biology.
Is CRNX A Good Stock To Buy Now?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Piling Into Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Should You Avoid Crinetics Pharmaceuticals, Inc. (CRNX)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On Crinetics Pharmaceuticals, Inc. (CRNX)
How do we determine whether Crinetics Pharmaceuticals, Inc.
Hedge Funds Have Never Been This Bullish On Crinetics Pharmaceuticals, Inc. (CRNX)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Here’s What Hedge Funds Think About Crinetics Pharmaceuticals, Inc. (CRNX)
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
Hedge Fund and Insider Trading News: D.E. Shaw, Appaloosa Management, CQS Cayman LP, Adamis Pharmaceuticals Corp (ADMP), Equitrans Midstream Corp (ETRN), and More
(Reuters) - Activist investor Appaloosa LP responded to proposed concessions from the board of Allergan Plc by saying it had done everything “except what needs to be done” ...
